AnovaOS Network Powered Patient Registry

Neoplasms Clinical Trial

Official title:

AnovaOS Network Powered Patient Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05013944
• Other study ID #: ANOVA-001-NPPR
• Status: Recruiting
• Start date: September 1, 2021
• Est. completion date: August 31, 2026

Study information

• Verified date: January 2024
• Source: Anova Enterprises, Inc
• Contact: Christopher Beardmore
• Phone: +1 (224) 218-2408
• Email: chris[@]anovaevidence.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Description:

The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100000
• Est. completion date: August 31, 2026
• Est. primary completion date: August 31, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years old or older;
• Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
• Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
• Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
• Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
• Anticipated additional follow up with the registry once per year.

Exclusion Criteria:

• Subjects who do not meet the inclusion criteria for the study;
• Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Related Conditions & MeSH terms

• Chromosome Aberrations
• Chromosome Disorders
• Communicable Diseases
• Congenital Abnormalities
• Digestive System Diseases
• Diseases of the Circulatory System
• Diseases of the Digestive System
• Diseases of the Nervous System
• Endocrine, Nutritional and Metabolic Diseases (E00-E89)
• External Causes of Morbidity and Mortality
• Hematologic Diseases
• Infections
• Infectious Disease
• Metabolic Diseases
• Neoplasms
• Nervous System Diseases
• Poisoning
• Pregnancy, Childbirth and the Puerperium
• Respiration Disorders
• Urogenital Diseases

Locations

Country	Name	City	State
United States	Anova Enterprises, Inc.	Arlington Heights	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Anova Enterprises, Inc

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assess Natural history	Assessing natural history, including estimating the magnitude of a problem; determining the underlying incidence or prevalence rate of a condition; examining trends of disease over time; assessing service delivery and identifying groups at high risk; and describing and estimating survival;	5 years
Primary	Assess Clinical, Cost and/or Comparative Effectiveness	Determining clinical effectiveness, cost effectiveness, or comparative effectiveness of a test or a treatment;	5 years
Primary	Assess Safety	Measuring and monitoring safety and harm associated with the use of specific products and treatments, including conducting comparative evaluation of safety and effectiveness;	5 years
Primary	Measuring and/or Improving Quality of Care	Measuring or improving quality of care, including conducting programs to measure and/or improve the practice of medicine and/or public health.	5 years

External Links

•   Further Registry Information
•   Registry Sign up